Shrouq Kamel Qaisi

Papers

Total Citations

H-Index

About

Shrouq Kamel Qaisi is a leading figure in the advancement of automated pharmacy systems, with a primary research focus on the safety, efficiency, and quality assurance of intravenous (IV) antineoplastic compounding. Her most cited work, a landmark three-year study of a first-generation chemotherapy-compounding robot, provides critical, long-term performance data on automated systems. This research, which has garnered 39 citations, meticulously evaluated the robot's ability to reduce human error, minimize occupational exposure to hazardous drugs, and improve preparation accuracy in a clinical setting. By documenting the real-world implementation and outcomes of the CytoCare robot at a Saudi Arabian hospital, Qaisi's work serves as a foundational reference for hospitals worldwide considering the transition from manual to robotic compounding. Her contributions are particularly significant in the field of oncology pharmacy, where her findings directly support the adoption of technology to enhance patient safety and protect healthcare workers. Through this pivotal study, Qaisi has established herself as a key voice in the conversation on automation in sterile compounding.